NAD Research Inc
NAD Research Inc. is a non-profit 501(c)(3) private foundation dedicated to research into nicotinamide adenine dinucleotide, NAD+, as it relates to its role in the management of addiction, neurodegenerative diseases, aging, and other diseases and/or disorders reflective of mitochondrial dysfunction.
Our lab currently measures levels of NAD, NADH, NAD/NADH ratios with the goal of understanding how these values impact health:
Pilot studies are measuring biomarkers for oxidative stress and inflammation and demonstrating very encouraging results.
Pilot studies are showing a positive response to nitric oxide with use of IV NAD+.
Pilot studies have explored the positive effects IV NAD+ displays on cognitive health and results will be displayed at the 2019 Society for Neuroscience conference.
Pilot studies are showing great success for addiction recovery, specifically pertaining to withdrawal symptoms, cravings and relapse rates.
NAD Research Inc is in collaboration with leading researchers worldwide, including the Australian Research Group and Louisiana State University. NAD Research Inc has published in the Society for Neuroscience, and will soon publish a peer-reviewed pharmacokinetic study.
To see a full list of our published research, and to see our on-going research projects, please click the button below to visit the NAD Research Inc website.
Donate For a Cause
We understand the national crisis surrounding drug and alcohol addiction, and it is our mission is to provide published data that reflects how powerful IV NAD therapy can be towards helping individuals recover more effectively. Publishing more peer reviewed data on drug and alcohol detoxification with IV NAD will give us more of a scientific ground to stand on before we launch a clinical opioid detoxification study.
Privacy and Cookies Policy